Skip to main content
. 2017 Jan 13;12(1):e0169624. doi: 10.1371/journal.pone.0169624

Fig 5. Distribution of patients in SIR and TAC groups depending on the pretransplant donor specific T-cell alloimmune response assessed by IFN-γ Elispot.

Fig 5

Negative group: <20 spots/ 300 000 PBMC; positive group: >20 spots/ 300 000 PBMC.